The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth - Hyun-Jin Tae; Ji Min Kim; Sungha Park; Noboru Tomiya; Geng Li; Wen Wei; Natalia Petrashevskaya; Ismayil Ahmet; John Pang; Stefanie Cruschwitz; Rebecca A. Riebe; Yinghua Zhang; et al. (Journal of Molecular Medicine, 2013)